Effect of the deletion of US2 and US3 from herpes simplex virus type 2 on immune responses in the murine vagina following intravaginal infection

Author： Inagaki-Ohara K. Iwasaki T. Watanabe D. Kurata T. Nishiyama Y.

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.20, Iss.1, 2001-10, pp. : 98-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intranasal immunization with recombinant gD2 reduces disease severity and mortality following genital challenge with herpes simplex virus type 2 in guinea pigs

By O'Hagan D. Goldbeck C. Ugozzoli M. Ott G. Burke R.L.

Vaccine, Vol. 17, Iss. 18, 1999-05 ,pp. : 2229-2236

Elsevier

Access to resources Recommend Favorite

DNA immunization utilizing a herpes simplex virus type 2 myogenic DNA vaccine protects mice from mortality and prevents genital herpes

By Gebhard J.R.J.R. Zhu J. Cao X. Minnick J. Araneo A.B.A.

Vaccine, Vol. 18, Iss. 17, 2000-03 ,pp. : 1837-1846

Elsevier

Access to resources Recommend Favorite

Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus

By Gallichan W.S. Rosenthal K.L.

Vaccine, Vol. 13, Iss. 16, 1995-11 ,pp. : 1589-1595

Elsevier

Access to resources Recommend Favorite

Immunity induced by DNA immunization with herpes simplex virus type 2 glycoproteins B and C

By Mester J.C. Twomey T.A. Tepe E.T. Bernstein D.I.

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 875-883

Elsevier

Access to resources Recommend Favorite

DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2

By Bourne N. Milligan G.N. Schleiss M.R. Bernstein D.I. Stanberry L.R.

Vaccine, Vol. 14, Iss. 13, 1996-09 ,pp. : 1230-1234

Elsevier

Access to resources Recommend Favorite